Clinical Trials Directory

Trials / Conditions / Metastatic Dedifferentiated Liposarcoma

Metastatic Dedifferentiated Liposarcoma

6 registered clinical trials studyying Metastatic Dedifferentiated Liposarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) fo
NCT06498648
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Po
NCT06422806
National Cancer Institute (NCI)Phase 3
RecruitingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert
NCT05711615
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
NCT05694871
Alliance for Clinical Trials in OncologyPhase 2
Active Not RecruitingA Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
NCT05886634
Memorial Sloan Kettering Cancer CenterPhase 2
Active Not RecruitingOleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
NCT04668300
M.D. Anderson Cancer CenterPhase 2